New executive leadership team as of April 1, 2013

Novozymes executive management will organize into a functional structure with all current Executive Vice Presidents and joined by Andrew Fordyce. Today VP of Sales and Customer Solutions, Andrew Fordyce, 49, has been with the company since 1993, holding positions in commercial operations, R&D and production in Denmark, Switzerland and the US. 

The Board of Directors of Novozymes has appointed Peder Holk Nielsen as President and Chief Executive Officer with effect from April 1, 2013. “I am #

 

President & CEO: Peder Holk Nielsen 

Business Development: EVP Thomas Videbæk 

Business Operations: EVP Andrew Fordyce 

Supply Operations: EVP Thomas Nagy   

Research & Development: EVP and CSO Per Falholt  

Corporate Functions: EVP and CFO Benny D. Loft 

 

About Novozymes

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow’s industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever-changing marketplace.